Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than ...

Cases of ocular side effects have emerged in greater frequency both in new and established therapies than were seen in many clinical trials.

Prevalence of Eye Toxicities in Patients With Cancer Is Much Higher ...

In the real-world setting, cases of ocular adverse effects have emerged with greater frequency both in new and established therapies than has ...

Eye Toxicities: A Side Effect of Cancer Treatment | Cleveland Clinic

They can also cause eye toxicities. So, we've been seeing a lot more with the new drugs which include these targeted therapies, checkpoint ...

Ocular Side Effects of New Cancer Agents - Review Education Group

Patients should be educated thoroughly on possible ocular side effects, including blurred vision and dry eye, prior to starting treatment so ...

Ocular adverse effects of anti-cancer chemotherapy - PubMed Central

Additionally, studies have shown that epiphora (excessive tearing) is more prevalent in patients receiving weekly docetaxel treatment compared to those on a ...

New Ovarian Cancer Drug Can Affect the Eyes, Suggests First Real ...

Unfortunately, these newer medications can cause a variety of side effects on the eyes, including blurry vision, cornea toxicity, dry eye, and ...

Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review

Imatinib, Conjunctivitis, blurry vision, eyelid edema, conjunctival hemorrhage, dry eye, periorbital edema (most common), also rarely papilledema, glaucoma, ...

The ocular side effects of emerging oncology meds - Retina Specialist

As clinicians embrace and employ these novel immunotherapies, targeted therapies and chemotherapy agents, distinct potential adverse events ...

Cancer Treatment and the Eyes - Modern Optometry

The most common ocular side effects of anticancer medications are related to dry eye and conjunctivitis. ... effects of treatments commonly used for patients with ...

8 cancer treatment-related eye changes and how to manage them

Eye and vision problems are a common side effect of some types of cancer treatment. Nagham Al-Zubidi, M.D., explains the most common ...

Ocular Toxicity of New-Age Cancer Therapies - Retina Today

Cancer vaccines have not yet been linked to significant retinal side effects; however, given the experience of patients undergoing other immunotherapies, it is ...

Ocular adverse events associated with immune checkpoint inhibitors ...

It is thought that 1% of the patients treated with ICIs develop ocular side effects [3, 5]. ... more prevalent in lung cancer compared to melanoma ...

Your eyes and cancer drugs - Cancer Research UK

Some cancer drugs can cause changes to your eyes and your eyesight. But there are treatments that can help and things you can do to cope.

Ocular side effects of oncological therapies: Review - ScienceDirect

The number of drugs used has increased exponentially in number, and although the implicit toxicity is lower than that of conventional antineoplastic therapy, ...

Eye and vision problems | Canadian Cancer Society

Sometimes eye and vision problems happen as late effects years after having cancer treatment. How the eyes work. The eyes sit in a ...

Ocular toxicity and cancer chemotherapy: A review

more affected than white patients or patients of Afri- can des~ent ... Blepharoconjunctivitis: a side effect of 13 cis-retinoic acid therapy for ...

Systemic Chemotherapy and Ocular Toxicities - EyeWiki

Ocular treatment related adverse effects (TRAE) can occur with MEK or BRAF ... The most common ocular adverse effect associated with aromatase ...

Ocular Side Effects Common in Real-World Study of Cancer Tx

CHICAGO — A real-world study of the ocular side effects of the gynecological cancer treatment mirvetuximab (Elahere) has found more than two ...

Targeted Cancer Therapy and Its Ophthalmic Side Effects: A Review

The most common was uveitis followed by conjunctivitis and dry eye. These IRAE did not warrant treatment discontinuation. Shailesh et al ...

Ocular toxicities associated with targeted anticancer agents

This high frequency of ocular adverse events can be partially attributed to the delicate homeostatic environment of growth factors, cell ...